Figure 7.
Sphingolipid accumulation and abundance changes are organ specific in the Asah1P361R/P361R;MCP-1−/− mice. Percentage distribution of all total sphingolipids measured in liver, lung, and brain tissue lysates (A–C). Ceramide (Cer) species in liver, lung, and brain (D–F). Relative abundance of Cer species in liver, lung, and brain (G–I). Sphingomyelin (SM) species in liver, lung, and brain (J–L) and relative abundance of SM species in liver, lung, and brain (M–O). n = 4–6 per genotype. All comparisons were made between samples from 8–9-week-old Asah1P361R/P361R;MCP-1+/+, 8–9-week-old Asah1P361R/P361R;MCP-1−/− and 11–12-week-old Asah1P361R/P361R;MCP-1−/− mice. ns (not significant), *Represents post-hoc test compared to Asah1+/+;MCP-1+/+ *p < 0.05, **p < 0.01,***p < 0.001. #Represents post-hoc test compared to Asah1P361R/P361R;MCP-1+/+ #p < 0.05.